Jun‐Cheng Su
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Bioactive Natural Diterpenoids Research 7
- Natural product bioactivities and synthesis 5
-
- Quinazolinone synthesis and applications 7
- Catalytic C–H Functionalization Methods 6
- Co-authors
- Wen‐Cai Ye (10 shared papers)Ying Wang (9 shared papers)Xiao‐Jun Huang (9 shared papers)Yao-Lan Li (5 shared papers)Jian‐Guo Song (6 shared papers)Ren‐Wang Jiang (3 shared papers)Wei Tang (4 shared papers)Qiao‐Yun Song (3 shared papers)
In The Last Decade
Jun‐Cheng Su
42 papers receiving 580 citations
Peers
Comparison fields: 5 of 70
- Toxicology 44
- Pharmacology 170
- Biotechnology 79
- Pharmacology 55
- Drug Discovery 1
Countries citing papers authored by Jun‐Cheng Su
This map shows the geographic impact of Jun‐Cheng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Cheng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Cheng Su more than expected).
Fields of papers citing papers by Jun‐Cheng Su
This network shows the impact of papers produced by Jun‐Cheng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Cheng Su. The network helps show where Jun‐Cheng Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun‐Cheng Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 52 | |
| 2 | 2019 | 49 | |
| 3 | 2019 | 47 | |
| 4 | 2018 | 41 | |
| 5 | 2020 | 30 | |
| 6 | 2021 | 28 | |
| 7 | 2021 | 26 | |
| 8 | 2021 | 24 | |
| 9 | 2020 | 21 | |
| 10 | 2018 | 20 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 18 | |
| 13 | 2021 | 18 | |
| 14 | 2021 | 15 | |
| 15 | 2024 | 15 | |
| 16 | 2017 | 14 | |
| 17 | 2022 | 14 | |
| 18 | 2023 | 13 | |
| 19 | 2020 | 13 | |
| 20 | 2022 | 11 |
About Jun‐Cheng Su
Jun‐Cheng Su is a scholar working on Molecular Biology, Organic Chemistry, Plant Science, Pharmacology and Pharmacology, having authored 50 papers that have together received 585 indexed citations. Recurring topics across this work include Phytochemistry and Biological Activities (8 papers), Quinazolinone synthesis and applications (7 papers), Natural Compound Pharmacology Studies (7 papers), Bioactive Natural Diterpenoids Research (7 papers), Microbial Natural Products and Biosynthesis (6 papers), Catalytic C–H Functionalization Methods (6 papers), Synthesis of Organic Compounds (6 papers) and Natural product bioactivities and synthesis (5 papers). The work is most often cited by research in Toxicology (44 citations), Pharmacology (170 citations), Biotechnology (79 citations), Pharmacology (55 citations) and Drug Discovery (1 citation). Jun‐Cheng Su has collaborated with scholars based in China, Australia and Thailand. Frequent co-authors include Wen‐Cai Ye, Ying Wang, Xiao‐Jun Huang, Yao-Lan Li, Jian‐Guo Song, Ren‐Wang Jiang, Wei Tang, Qiao‐Yun Song, Man‐Mei Li and Luo-Sheng Wan. Their work appears in journals such as Bioorganic Chemistry, Organic Letters, Fitoterapia, Journal of Natural Products and Organic Chemistry Frontiers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.